Evidence on the association of nocturnal hypertension (NH) with subclinical cardiac and vascular damage is scanty. The authors performed a meta-analysis to provide comprehensive information on this clinically relevant issue. Full articles providing data on subclinical cardiac and carotid damage as assessed by ultrasonographic methods in patients with NH as compared with patients with nocturnal normotension (NN) were considered. A total of 3657 patients (NH=2083, NN=1574) of both sexes were included in seven studies. A growing body of evidence indicates that nighttime blood pressure (BP) is more closely related to subclinical organ damage and cardiovascular prognosis than 24-hour and daytime BPs.1 A mounting body of evidence also indicates that nighttime BP is a better predictor of alterations in target organs and cardiovascular events than the nondipping pattern.2,3 The clinical value of the dipping/nondipping classification has been questioned based on pathophysiological and methodological considerations. First, dipping/nondipping categorization is strongly dependent on daytime BP values, which, in turn, are related to multiple variables including degree of physical activity, emotional state, coffee/ alcohol drinking, smoking habit, and seasonal variability.4,5 Second, both dipping and nondipping patterns have been shown to have a limited reproducibility over short-and long-term periods in the setting of essential hypertension.6,7 Third, dipping pattern is not synonymous with normal nighttime BP, as it may be associated with nocturnal hypertension (NH) according to current hypertension guideline cutoffs (ie, BP >120/70 mm Hg). 8 NH has been reported to convey a higher risk of vascular and cardiac morphofunctional alterations as well as of nonfatal and fatal cardiovascular events and all-cause mortality regardless daytime BP values.Findings from the International Database of Ambulatory Blood Pressure involving 8711 individuals from 10 populations showed that patients with isolated NH (ie, daytime BP <135/85 mm Hg and nighttime BP ≥120/70 mm Hg) exhibited higher risks of total mortality (+29%, P=.04) and all cardiovascular events (+38%, P=.003) compared with their counterparts with nocturnal normotension (NN). 9 The stronger predictive value of nocturnal systolic BP over daytime BP has been documented by a review of 24 prospective studies including 23,856 hypertensive patients and 9641 individuals from population-based cohorts.10 Furthermore, among 859 diabetic patients followed-up for 5 years in the Dublin Outcome Study, nighttime systolic BP was a powerful independent predictor of cardiovascular mortality, after adjustment for age, sex, body mass index (BMI), smoking, previous cardiovascular disease, and daytime BP.11 The resultant hazard ratios and 95% confidence intervals (CIs) associated with a 10-mm Hg increase in systolic nighttime BP were 1.32 (CI, 1.12-1.69), 1.95 (CI,, and 1.24 (CI, 0.99-1.56) for total cardiovascular events, stroke, and cardiac mortality, respectively. Notably, the fully adjusted 5-yea...